TAPSE/PAi, a practical echocardiographic functional–structural index, better reflects functional severity than TAPSE/sPAP in pulmonary hypertension
Open Access
- 8 May 2026
- journal article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Abstract
We evaluated TAPSE/PAi, defined as the ratio of tricuspid annular plane systolic excursion to the indexed main pulmonary artery diameter, as a pragmatic functional-structural index and compared it with TAPSE/sPAP. In this retrospective study, 53 patients with PAH were analyzed. Associations of TAPSE/PAi and TAPSE/sPAP with clinical, biomarker, and invasive hemodynamic variables were assessed. Discrimination for WHO-FC ≥ 3, 6MWD < 165 m, and PVR > 5 WU was evaluated by direction-aligned ROC analysis with Youden-optimal thresholds. Age- and sex-adjusted logistic regression models reported odds ratios (ORs) per 1-SD increase. TAPSE/PAi correlated more strongly than TAPSE/sPAP with WHO-FC (ρ=-0.592 vs. -0.384) and 6MWD (ρ = 0.493 vs. 0.378), whereas TAPSE/sPAP correlated more strongly with NT-proBNP/proBNP (ρ=-0.619 vs. -0.484) and with mPAP/PVR. TAPSE/PAi showed better discrimination for WHO-FC ≥ 3 and 6MWD < 165 m while TAPSE/sPAP performed modestly better for PVR > 5 WU The Youden-optimal TAPSE/PAi threshold was ≤ 1.296 for both WHO-FC ≥ 3 and 6MWD < 165 m. The higher TAPSE/PAi remained associated with lower odds of WHO-FC ≥ 3 and 6MWD < 165 m after age- and sex-adjustment. TAPSE/PAi better reflects functional severity and exercise limitation, whereas TAPSE/sPAP is more closely related to biomarker/hemodynamic burden. The indices appear complementary, and TAPSE/PAi may be a practical TR-independent severity marker in PAH.Keywords
This publication has 23 references indexed in Scilit:
- Novel Reference Equations for Pulmonary Artery Size and Pulsatility Using Echocardiography and Their Diagnostic Value in Pulmonary HypertensionChest, 2024
- The ‘Ten Commandments’ of the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Heart Journal, 2023
- The evolving landscape of pulmonary arterial hypertension clinical trialsThe Lancet, 2022
- Prognostic factors of pulmonary hypertension associated with connective tissue disease: pulmonary artery size measured by chest CTRheumatology, 2020
- A four-tier classification system of pulmonary artery metrics on computed tomography for the diagnosis and prognosis of pulmonary hypertensionJournal of Cardiovascular Computed Tomography, 2018
- Methods for Evaluating Right Ventricular Function and Ventricular–Arterial CouplingProgress in Cardiovascular Diseases, 2016
- RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertensionHeart, 2014
- Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertensionInternational Journal of Cardiology, 2013
- Methods for Measuring Right Ventricular Function and Hemodynamic Coupling with the Pulmonary VasculatureAnnals of Biomedical Engineering, 2013
- Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysisHeart, 2011